Lista de obras - Øivind Torkildsen - Dominio Público Uruguay

1,25-Dihydroxyvitamin-D3 induces brain proteomic changes in cuprizone mice during remyelination involving calcium proteins

artículo científico publicado en 2017

A man in his 60's with acute headache ⬇️

artículo científico publicado el 27 de marzo de 2012

A need for national registries and international collaborative research in multiple sclerosis

artículo científico publicado en 2012

A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination

artículo científico publicado en 2008

Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction

artículo científico publicado en 2013

An Update on Vitamin D and Disease Activity in Multiple Sclerosis

artículo científico publicado en 2019

An update on cladribine for relapsing-remitting multiple sclerosis

artículo científico

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis

artículo científico publicado en 2014

B cell depletion in the treatment of multiple sclerosis

artículo científico publicado en 2019

Body mass index influence interferon-beta treatment response in multiple sclerosis

artículo científico publicado en 2015

Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia.

artículo científico publicado en 2016

Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?

artículo científico publicado en 2016

Cerebrospinal fluid proteomics in multiple sclerosis

artículo científico

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

artículo científico publicado en 2015

Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model

artículo científico publicado en 2013

Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis.

artículo científico publicado en 2016

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model

artículo científico publicado en 2011

Disease-modifying treatments for multiple sclerosis - a review of approved medications

artículo científico publicado en 2016

Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model

artículo científico publicado en 2014

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

artículo científico publicado en 2016

Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination

artículo científico publicado en 2008

Effects of vitamin D on axonal damage during de- and remyelination in the cuprizone model

artículo científico publicado en 2018

Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation

artículo científico publicado en 2012

Epstein-Barr virus reactivation and multiple sclerosis

artículo científico publicado en 2007

Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations

artículo científico publicado en 2005

Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population

artículo científico publicado en 2005

Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab

scientific article published on 19 July 2018

Family planning, pregnancy and breastfeeding in multiple sclerosis

artículo científico publicado en 2016

Fat-soluble vitamins as disease modulators in multiple sclerosis

artículo científico publicado en 2013

FcgammaR and multiple sclerosis: an overview

artículo científico publicado en 2006

Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls

scientific article published on 01 January 2012

Fingolimod does not enhance cerebellar remyelination in the cuprizone model

artículo científico publicado en 2015

Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model

scientific article published on 31 October 2019

Glitazone use associated with reduced risk of Parkinson's disease

artículo científico publicado en 2017

High dose methylprednisolone induces FcgammaRI on granulocytes in MS-patients

artículo científico publicado en 2005

Immunomodulatory treatment of multiple sclerosis in Norway

scientific article published on 01 January 2007

Impact of the environment on multiple sclerosis

artículo científico publicado en 2015

In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis

artículo científico publicado en 2016

Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis

artículo científico publicado en 2014

Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity

artículo científico publicado en 2013

International consensus on quality standards for brain health-focused care in multiple sclerosis

article

Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.

artículo científico publicado en 2016

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study

scientific article published on 05 May 2016

Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders

artículo científico publicado en 2020

Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model

artículo científico publicado en 2015

Month of birth and risk of multiple sclerosis: confounding and adjustments

artículo científico publicado en 2014

Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway

artículo científico publicado en 2012

Month of birth as a risk factor for multiple sclerosis: an update.

artículo científico publicado en 2012

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis

scientific article published on 30 April 2020

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

artículo científico publicado en 2017

Neuromyelitis optica

artículo científico publicado en 2013

No association of tobacco use and disease activity in multiple sclerosis

artículo científico publicado en 2016

No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis

artículo científico publicado en 2013

Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation

artículo científico publicado en 2013

Polyunsaturated fatty acids in multiple sclerosis therapy.

artículo científico publicado en 2012

Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

artículo científico publicado en 2015

Re: Familieplanlegging, graviditet og amming ved multippel sklerose

artículo científico publicado en 2017

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments

artículo científico publicado en 2014

Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.

artículo científico publicado en 2015

Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patient

artículo científico publicado en 2018

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis

artículo científico publicado en 2012

Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study

scientific article published on 01 October 2019

Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway

scientific article published on 13 December 2019

Selective processing of linguistic and pictorial food stimuli in females with anorexia and bulimia nervosa.

artículo científico

Serum NFL levels should be used to monitor multiple sclerosis evolution - No

scientific article published on 18 October 2019

Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis

artículo científico publicado en 2018

Severe multiple sclerosis reactivation after gonadotropin treatment

artículo científico publicado en 2018

Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway

artículo científico publicado en 2013

The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis

artículo científico publicado en 2016

The Norwegian Multiple Sclerosis Registry and Biobank.

artículo científico

The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS)

artículo científico publicado en 2019

The cuprizone model for demyelination

artículo científico publicado en 2008

The cuprizone model: regional heterogeneity of pathology

artículo científico publicado en 2012

Thrombolytic therapy and thrombectomy in unknown stroke onset

artículo científico publicado en 2016

Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.

artículo científico publicado en 2015

Treatment of multiple sclerosis under the COVID-19 pandemic

artículo científico publicado en 2020

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS.

artículo científico publicado en 2014

Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients

artículo científico publicado en 2009

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment

artículo científico publicado en 2012

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis

artículo científico publicado en 2015

Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore

artículo científico publicado en 2012

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis

artículo científico publicado en 2015

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.

artículo científico publicado en 2016

Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis

artículo científico publicado en 2008

Vitamin D–Dependent Rickets, HLA-DRB1, and the Risk of Multiple Sclerosis

WT1 and interferon-β-vitamin D association in MS: a longitudinal study

scientific article published on 02 June 2015

[Re: Vitamin D--how much is enough, and is more better for your health?]

artículo científico publicado en 2014

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients

artículo científico publicado en 2018

ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial

artículo científico

Lista de obras de Øivind Torkildsen

1,25-Dihydroxyvitamin-D3 induces brain proteomic changes in cuprizone mice during remyelination involving calcium proteins

A man in his 60's with acute headache ⬇️

A need for national registries and international collaborative research in multiple sclerosis

A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination

Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction

An Update on Vitamin D and Disease Activity in Multiple Sclerosis

An update on cladribine for relapsing-remitting multiple sclerosis

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis

B cell depletion in the treatment of multiple sclerosis

Body mass index influence interferon-beta treatment response in multiple sclerosis

Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia.

Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?

Cerebrospinal fluid proteomics in multiple sclerosis

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model

Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis.

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model

Disease-modifying treatments for multiple sclerosis - a review of approved medications

Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination

Effects of vitamin D on axonal damage during de- and remyelination in the cuprizone model

Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation

Epstein-Barr virus reactivation and multiple sclerosis

Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations

Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population

Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab

Family planning, pregnancy and breastfeeding in multiple sclerosis

Fat-soluble vitamins as disease modulators in multiple sclerosis

FcgammaR and multiple sclerosis: an overview

Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls

Fingolimod does not enhance cerebellar remyelination in the cuprizone model

Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model

Glitazone use associated with reduced risk of Parkinson's disease

High dose methylprednisolone induces FcgammaRI on granulocytes in MS-patients

Immunomodulatory treatment of multiple sclerosis in Norway

Impact of the environment on multiple sclerosis

In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis

Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis

Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity

International consensus on quality standards for brain health-focused care in multiple sclerosis

Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study

Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders

Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model

Month of birth and risk of multiple sclerosis: confounding and adjustments

Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway

Month of birth as a risk factor for multiple sclerosis: an update.

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

Neuromyelitis optica

No association of tobacco use and disease activity in multiple sclerosis

No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis

Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation

Polyunsaturated fatty acids in multiple sclerosis therapy.

Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

Re: Familieplanlegging, graviditet og amming ved multippel sklerose

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments

Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.

Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patient

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis

Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study

Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway

Selective processing of linguistic and pictorial food stimuli in females with anorexia and bulimia nervosa.

Serum NFL levels should be used to monitor multiple sclerosis evolution - No

Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis

Severe multiple sclerosis reactivation after gonadotropin treatment

Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway

The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis

The Norwegian Multiple Sclerosis Registry and Biobank.

The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS)

The cuprizone model for demyelination

The cuprizone model: regional heterogeneity of pathology

Thrombolytic therapy and thrombectomy in unknown stroke onset

Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.

Treatment of multiple sclerosis under the COVID-19 pandemic

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS.

Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients